Literature DB >> 17482159

Activity of two different polyglucosamines, L112 and FF45, on body weight in male rats.

Giampietro Bondiolotti1, Silvio R Bareggi, Natale G Frega, Silvana Strabioli, Umberto Cornelli.   

Abstract

L112 and FF45 are two polyglucosamines with similar characteristics and molecular weights. Three groups of 15 young male rats each were fed a standard diet or a diet containing 2% L112 or FF45 for 4 weeks, and we measured their body weight; water and food intake; triglyceride and total, low-density lypoproteins (LDL) and high-density lypoproteins (HDL) cholesterol levels; and the amount of feces and fecal water and lipid concentrations. The results showed that both L112 and FF45 reduced the increase in body weight in comparison with controls (respectively 152+/-18.7 g and 155+/-18.7 g vs 166+/-18.1 g; ANOVA P<0.05). Total food intake during the study period was significantly greater in the animals treated with L112 or FF45 (respectively 780+/-49.9 g and 787+/-61.7 g vs 742+/-53.0 g), with a significant loss of "food efficiency". Water intake was similar in all three groups. There was no significant change in plasma lipid profiles in any of the groups except for a significant decrease in HDL cholesterol in the animals treated with L112. Twenty-four-hour fecal weight was 7.8+/-1.70 g in the controls, 10.1+/-1.98 g in the rats treated with L112, and 9.0+/-1.21 g in those treated with FF45 (Dunnet's test vs controls: P<0.05). Fecal lipid and water concentrations were significantly higher in the polyglucosamine-treated groups (P<0.05 Dunnet's test).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482159     DOI: 10.1016/j.ejphar.2007.03.054

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Randomised, double-blind, clinical investigation to compare orlistat 60 milligram and a customized polyglucosamine, two treatment methods for the management of overweight and obesity.

Authors:  Manfred Stoll; Norman Bitterlich; Umberto Cornelli
Journal:  BMC Obes       Date:  2017-01-11

Review 2.  Recent Advances in Marine-Based Nutraceuticals and Their Health Benefits.

Authors:  Vida Šimat; Nariman Elabed; Piotr Kulawik; Zafer Ceylan; Ewelina Jamroz; Hatice Yazgan; Martina Čagalj; Joe M Regenstein; Fatih Özogul
Journal:  Mar Drugs       Date:  2020-12-09       Impact factor: 5.118

3.  Efficacy of polyglucosamine for weight loss-confirmed in a randomized double-blind, placebo-controlled clinical investigation.

Authors:  Karina Pokhis; Norman Bitterlich; Umberto Cornelli; Giuseppina Cassano
Journal:  BMC Obes       Date:  2015-06-10

4.  Effect of Polyglucosamine on Weight Loss and Metabolic Parameters in Overweight and Obesity: A Systemic Review and Meta-Analysis.

Authors:  Simone Perna; Sana N M Basharat; Khawla F Ali; Abdulla Eid; Clara Gasparri; Vittoria Infantino; Milena A Faliva; Maurizio Naso; Roberta Cazzola; Benvenuto Cestaro; Mariangela Rondanelli
Journal:  Nutrients       Date:  2020-08-07       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.